Perrigo Quarterly Cash Flow Statement
NYSE: PRGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Perrigo free cash flow
In the quarter ended Jun 27, 2026, Perrigo generated $82.6 million of operating cash flow and spent $14.3 million on capital expenditures. That left free cash flow of $68.3 million, a free-cash-flow margin of 6.7% of revenue. Free cash flow was up 20.5% from the prior year's $56.7 million.
Perrigo returned $40.2 million to shareholders through dividends, equal to 59% of free cash flow. Free cash flow covered dividend payments 1.7 times.
Summary generated from market data by MetaCap's automated system. Methodology
Perrigo cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-27 | Q1 20262026-03-28 | Q4 20252025-12-31 | Q3 20252025-09-27 | Q2 20252025-06-28 | Q1 20252025-03-29 | Q4 20242024-12-31 | Q3 20242024-09-28 | Q2 20242024-06-29 | Q1 20242024-03-30 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 74.50M | -398.60M | -1.42B | 7.50M | -8.40M | -6.40M | -44.50M | -21.00M | -108.40M | 2.00M | -32.30M | 14.20M |
| Net Income growth (YoY) | — | — | — | — | — | -420.00% | — | -247.89% | -1390.48% | — | — | — |
| Depreciation & Amortization | 95.80M | 83.30M | 85.90M | 85.40M | 86.30M | 79.90M | 80.30M | 82.30M | 81.90M | 81.40M | 85.90M | 91.00M |
| Stock-Based Compensation | 6.80M | 14.40M | 13.00M | 13.20M | 16.80M | 11.60M | 19.90M | 5.90M | 23.00M | 15.60M | 10.60M | 14.70M |
| Change in Working Capital | 36.00M | -196.30M | 158.80M | -47.70M | -32.80M | -179.40M | 161.80M | -17.60M | -92.20M | -126.70M | 129.20M | -21.10M |
| Operating Cash Flow | 82.60M | -113.60M | 175.40M | 51.70M | 75.90M | -64.50M | 312.60M | 42.20M | 9.50M | -1.40M | 208.70M | 124.50M |
| Capital Expenditures | -14.30M | -13.80M | -26.80M | -21.90M | -19.20M | -25.50M | -37.70M | -27.10M | -28.40M | -25.10M | -26.70M | -31.80M |
| Investing Cash Flow | 349.40M | -12.40M | -24.50M | -21.40M | -3.80M | -25.70M | -37.10M | 212.70M | -73.30M | -23.50M | -22.80M | -30.70M |
| Dividends Paid | -40.20M | -39.90M | -39.90M | -39.90M | -38.90M | -40.60M | -39.60M | -37.60M | -37.70M | -37.60M | -37.60M | -38.90M |
| Debt Issued | 0 | 427.60M | 0 | 0 | 0 | 0 | -1.50M | — | — | — | 295.10M | 0 |
| Debt Repaid | -335.00M | -424.30M | -8.70M | -8.50M | -8.80M | -8.80M | -1.11B | -400.80M | -9.80M | -9.80M | -301.30M | -9.10M |
| Financing Cash Flow | -388.90M | -45.30M | -54.40M | -50.30M | -54.00M | -61.80M | -1.15B | 653.30M | -49.80M | -60.40M | -44.60M | -43.30M |
| Net Change in Cash | 40.20M | -174.40M | 99.50M | -19.80M | 37.10M | -141.70M | -904.70M | 920.70M | -115.70M | -92.80M | 153.00M | 43.10M |
| Free Cash Flow | 68.30M | -127.40M | 148.60M | 29.80M | 56.70M | -90.00M | 274.90M | 15.10M | -18.90M | -26.50M | 182.00M | 92.70M |
This table shows 12 quarterly periods of Perrigo's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PRGO's reporting calendar. What is a cash flow statement?